Bpifrance

Bpifrance Financement S.A. is a French financial institution that provides a range of financing solutions and support services aimed at fostering the growth of startups, small and medium-sized enterprises (SMEs), and mid-cap companies. It offers various financial products, including medium to long-term loans, export insurance, and leasing options for both tangible and intangible assets. Additionally, Bpifrance supports companies through consulting services, guarantees for bank financing, and training for executives. The organization also engages in direct investments and manages funds aimed at enhancing the financial landscape for businesses at different stages of their development. Established in 1980 and based in Maisons-Alfort, France, Bpifrance was formerly known as OSEO S.A. and rebranded in July 2013. It operates as a subsidiary of Bpifrance SA, reinforcing its commitment to bolstering the French economy through diversified financial solutions.

Céline André

Investment Director

Adonis Arnaud

Junior Investment Manager

Laurent Arthaud

Managing Director

Françis Aymard

Investment Director

Simon Beauroy

Director

Isabelle Bebear

Director for International and University

Soukanda Bentaleb

Investment Officer

Denis Biju-Duval

MD of Mezzanine division

Stéphane Boivert

Associate

Pascal Bordat

Investment Director

Charles-Henri Boyer

Associate

Émilie Brunet

Investment Director and Portfolio Manager

Caroline Butin-Gelineau

Senior Investment Director

Nathalie Carmona

Associate

Yoann Caujolle

Portfolio Director

Jocelyne Cerasa

Investment Director

Nicolas Ceria

Associate

Ménelé Chesnot

Senior Investment Director

Maufras Du Chatellier, Elyssa

Investment Director

Samuel Dalens

Investment Director

Florent Debienne

Managing Director | Head of Technology Funds Investments

Christian Deblaye

Deputy MD

Grégoire Delpit

Portfolio Director

Luc Doyennel

Investment Director

Nicolas Dufourcq

CEO

Jean-Yves Duriez

Investment Director

Antoine Emmanuelli

Partnership Director

Francis Estellat

Senior Investment Director

Yannick Etienne

Investment Manager

Alain Fakhoury

Investment Director Bretagne

Stephen Fargis

Associate

Arnaud Fauquembergue

Investment Manager

Olivier Fosse

Investment Director Alsace Champagne-Ardenne Lorraine

Jean-Marie Fougeray

Investment Director Bretagne

Stéphanie Frachet

Investment Director

Ronan Frefield

Portfolio Director

Marie-Laure Garrigues

Investment Director

Laurence Gauthier

Senior Investment Director Bourgogne Franche-Comté

Xavier Gelot

Director of Fonds de Renforcement des PME

Emmanuelle Gervais

Senior Investment Director

Isabelle Ginestet-Naudin

Deputy MD and Director of Sectorial Funds

Vanessa Giraud

Managing Director

Alessandro Gonella

Director

José Gonzalo

Executive Director Mid and Large Cap Direction

Jean-Michel Grau

Office and Institutional Relations MD

Alexis Guinard

Investment Director

Raphaël Guterman

Associate

Yonel Génin

Partnership Director

Luc Heinrich

MD

Hubert Hernandez

Investment Director

Hortense Jacon

Investment Associate

Véronique Jacq

Managing Director

Jean-René Jégou

Director of the Regional Funds Department

Pascal Lagarde

Director

Caroline Lebel

Senior Associate

Eric Lefebvre

Director

Ronan Lefort

Investment Director

Arnaud Legardeur

Investment Director

Benjamin Legourd

Investment Manager

Christian Leonetti

Investment Director

Olivier Levy

Director of East private equity Interregional Network

Martin Lochon

Associate

Cedric Lowenbach

Director of Operations

Arielle Marsaud

Associate

Alex Marvaldi

Partner

Laure Michel

Investment Director

Maud Moulin

Portfolio Director

Sébastien Moynot

Investment Director and Member of the Management Board

Philippe Mutricy

Deputy MD

Valérie de la Ménardière

Investment Director

Marinus Oosterbeek

Associate

Alexandre Ossola

MD

Stanislas Panhard

Senior Investment Director

Nicolas Parpex

Senior Investment Director

Emeline Parry

Investment Manager

Sophie Perette

Portfolio Director Alsace Champagne-Ardenne Lorraine

Thibault Peroys

Investment Director

Dominique Phelouzat

Incharge of Administration and Finance, CFO

Axel Piriou

Senior Investment Manager

Marc Prévôt

Director of North Private Equity Interregional Network

Matthieu Rabeisen

Portfolio Director

Sarah Roeland

Investment Manager

Stéphane Romang

Investment Director

Thibaut Roulon

Investment Director

Julie Régnier

Senior Investment Manager Alsace Champagne-Ardenne Lorraine

Eduardo Sampaio

Portfolio Director

Nadia Sarri

Investment Director

Gilles Schang

Deputy Managing Director

Nicolas de La Serre

Investment Director Pays de la Loire

Nicolas Sluys

Associate

David Smadja

Investment Manager

Thierry Sommelet

MD

Vincent Stievenard

Investment Director and Director of North Private Equity Interregional Network

Jonathan Szalavecz

Associate

Xavier Tessier

Director

Gabrielle Tetart

Senior Investment Manager and Associate

Tuan Tran

Investment Director

Alain Tueux

Investment Director

Stanislas de Tymowski

Associate

Adrien Vasseur

Portfolio Director

Luc Vernhet

Associate

Benoît Villain

Senior Investment Manager

Philippe Vuarchex

Associate

Stéphanie Vuillaume

Associate

Romain Vérani

Associate

Samuel Waddell

Associate

Tristan de Witte

Associate

Le Mintier Jonglez, Delphine

Investment Director

de Saint Lager, Benoist

Investment Director

Galamand Patard, Isabelle

Director

Past deals in Early Venture Stage

EyeLights

Series A in 2023
EyeLights SAS is a French company that specializes in designing and manufacturing GPS-enabled motorcycle helmets. Founded in 2016 and based in Labege, EyeLights offers a unique head-up display that projects navigation, warnings about hazards, and traffic information directly into a rider's line of sight, allowing them to maintain focus on the road. The system integrates with smartphones via Bluetooth, enabling users to listen to music, take calls, and program road trips using voice commands. The compact device can be installed in under five minutes on various helmet types and operates for over eight hours, providing clear visibility even in challenging weather conditions. Weighing less than 100 grams, the EyeLights product is designed for practicality and ease of use, enhancing the overall riding experience.

Kiro

Series A in 2023
Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.

Shortcut

Grant in 2022
Saas

Siteflow

Series A in 2022
Siteflow is a developer of cloud-based service management software tailored for complex industries such as nuclear, manufacturing, special works, and oil and gas. Established in 2017 and headquartered in Paris, France, the company offers Siteflow Builder, an application designed to streamline operations, ensure timely execution of tasks, track project status, and assess performance on work sites. The software facilitates collaboration among colleagues and standardizes business operations, addressing the unique challenges of regulated industries where traditional methods have remained unchanged for decades. By focusing on user-friendly interfaces and functionalities, Siteflow aims to enhance user acceptance and ease the digital transformation process. Additionally, the company supports organizations in redesigning their workflows to achieve operational excellence, helping professionals to focus on critical tasks while improving overall efficiency through real-time monitoring and automated reporting.

Osivax

Grant in 2022
​Osivax is a developer of immunotherapy vaccines intended to facilitate the treatment of infectious diseases. The company's vaccines expedite the uptake into dendritic cells and increase the immunogenicity of the natural protein to trigger a more effective immune response, including an unprecedented CD8 T cell activation, enabling medical practitioners to treat patients with cancer as well as influenza, malaria and other infectious diseases effectively.

Arianee

Series A in 2022
Arianee SA, founded in 2018 and based in Paris, France, specializes in providing digital certifications for products. The company has developed an Ethereum-compatible blockchain platform that modernizes the authentication process for branded products through a universal open-source protocol. This platform enables the recording of all elements involved in the creation and sale of products in an immutable ledger, ensuring that the data remains unalterable, deletable, or subject to shutdown. By doing so, Arianee facilitates collaboration among brands, owners, and third-party retailers, promoting a global standard for the digital certification of valuable items.

Implicity

Series A in 2022
Implicity is a developer of a remote monitoring platform that enables the smart monitoring of patients with connected pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on each patient's medical context. This innovative approach allows cardiologists and healthcare professionals to automate the remote monitoring process, consolidating patients' telepulse information into a single platform. By enhancing the efficiency of monitoring, Implicity aims to support hospital teams in delivering optimal quality care to their patients.

Handivoyage

Series A in 2022
Handivoyage SAS operates an online travel booking platform specifically designed for individuals with disabilities. Founded in 2016 and based in Lyon, France, the company offers a variety of services, including holiday and hotel bookings, as well as access to medical equipment, medical aid, and adapted transportation. Committed to continuous improvement, Handivoyage actively collects customer feedback through comprehensive questionnaires following each stay, allowing them to enhance their service quality. This focus on user experience is central to their mission of providing accessible travel options for people with disabilities.

Umiami

Series A in 2022
Developer of a plant-based food technology designed to reduce meat consumption. The company's technology offers plant-based whole-cuts that contain plant proteins, enabling consumers to have alternatives that mimic the taste, texture, and smell of meat.

Umiami

Series A in 2022
Developer of a plant-based food technology designed to reduce meat consumption. The company's technology offers plant-based whole-cuts that contain plant proteins, enabling consumers to have alternatives that mimic the taste, texture, and smell of meat.

Cairdac

Series A in 2022
Developer of a pacing device designed to maintain cardiac rhythm. The company's implanted leadless pacemakers incorporate a self-sustaining power patented technology harvesting the heart's kinetic energy and bringing disruptive technologies to conventional leadless pacemakers, enabling patients and healthcare professionals with cost-effective alternatives that will revolutionize patients' quality of life.

Invivox

Series A in 2022
Invivox is an innovative online platform that connects medical professionals for practical, in situ training sessions, primarily in small groups or one-on-one settings. By facilitating these interactions among doctors worldwide, Invivox aims to enhance medical education and ultimately improve patient care. The platform not only offers interactive online classes but also publishes weekly medical magazines and curates specialized training opportunities in collaboration with a network of international experts. Through these initiatives, Invivox democratizes access to knowledge in the healthcare sector, providing valuable mentorship across various medical specialties.

Archeon

Series A in 2022
Archeon is focused on creating innovative solutions for the monitoring, diagnosis, and treatment of critically ill patients in prehospital care. The company develops artificial intelligence-based technologies aimed at enhancing ventilation quality in emergency medical services. Its products are designed to be practical, user-friendly, and intuitive for emergency caregivers, providing real-time feedback on the quality of ventilation administered to patients. This approach aims to improve patient outcomes and support medical professionals in high-pressure situations.

Alice & Bob

Series A in 2022
Alice & Bob is a Paris-based company founded in 2020 that specializes in the manufacture of universal, error-free quantum computers. The company's innovative technology features self-correcting superconducting quantum bits, which allow for fault-tolerant quantum computing. This capability enables the execution of any quantum algorithm, thereby assisting industries and researchers in addressing complex challenges across various fields. By focusing on developing advanced quantum computing solutions, Alice & Bob aims to facilitate breakthroughs in solving significant problems in quantum research and industry applications.

Susu

Grant in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.

CarbonWorks

Series A in 2022
CarbonWorks is specialising in the use of microalgae to capture and utilise carbon dioxide.

Silvr

Series A in 2022
Silvr offers financial services to e-merchants who do not have access to bank credit and who have no vocation or desire to raise funds. Silvr's revenue-based financing is based on the performance of the companies they finance. Silvr supports entrepreneurs on the path to success.

Elicit Plant

Series A in 2022
Elicit Plant is an agro-biotech company specialized in crops’ water resistance and in the development of innovative phytosterol-based solutions.

Combo

Series A in 2022
Snapshift is a staff management web solution for restaurants. The company's software enables restaurant owners to make online scheduling and enter the information on contracts, endorsements, proofs, leave requests, time sheets which will be stored online, enabling restaurant owners spend less time on administrative tasks so they can focus on their customers.

Ascor Communication

Venture Round in 2022
Ascor Communication, a holding company, through its subsidiaries, provides digital and distance learning solutions. The company was incorporated in 2007 and is based in Rennes, France.

Cureety

Series A in 2022
Cureety SAS develops Cureety, an interoperable application to integrate into the daily life of all healthcare establishments. It provides researchers and industrialists with real-life data sources and a range of anti-tumor treatments. The company was incorporated in 2018 and is based in Dinan, France.

Signia Therapeutics

Grant in 2022
Signia Therapeutics proposes a breakthrough strategy to identify and repurpose rapidly, efficiently and at low cost already marketed drugs or to recycle unused drugs for new antiviral indication against several human respiratory viruses. These antiviral candidates could be directly evaluated in phase II clinical trials and/or quickly available in response to any widespread outbreak for which the medical community and patients have limited options.

Pherecydes Pharma

Grant in 2022
Pherecydes Pharma SA engages in the research and development of lytic bacteriophages for therapeutic and diagnostic applications with a focus on antibiotic resistance. It develops several banks of bacteriophages, including the collection of phages against Escherichia coli. The company was incorporated in 2006 and is based in Romainville, France.

Depixus

Series A in 2021
Depixus SAS is a biotechnology company based in Paris, France, focused on the development of advanced technology for extracting genetic and epigenetic information from single molecules of DNA and RNA. Its main product, SIMDEQ™ (SIngle-molecule Magnetic DEtection and Quantification), enables fast, accurate, and cost-effective analysis of genomes and epigenetic modifications. Initially developed at École Normale Supérieure by prominent researchers, SIMDEQ™ allows for the identification, counting, full sequencing, and epityping of millions of individual DNA molecules with high precision. The technology has broad applications in the life sciences and medical fields, facilitating real-time analysis of biomolecular interactions and supporting researchers in uncovering new biological pathways, understanding disease mechanisms, and advancing precision medicine. With substantial validation completed, Depixus is moving towards platform optimization and commercialization to enhance its offerings in these critical areas.

Meiogenix

Series A in 2021
Meiogenix SAS operates as a biotech company that develops breeding and genomic technologies. It offers SpiX technology, which modulates the process of homologous recombination in the genome by increasing its frequency in cold regions and PhoeniX, which is a non-GM method that induces meiotic recombination in hybrid diploid (or polyploid) yeast cells without the need to go through the entire process of meiosis. The company helps to develop new products to address global food and industrial challenges. The company was incorporated in 2010 and is based in Paris, France.

HypnoVR

Series A in 2021
HypnoVR SAS specializes in virtual reality-based medical hypnosis solutions aimed at managing pain and stress in patients. Founded in 2016 and based in Strasbourg, France, the company has developed a unique application that integrates virtual reality technology with medical hypnosis, effectively used in various medical fields, including pediatric surgery, gastroenterology, gynecology, and dental surgery. HypnoVR also focuses on research initiatives that explore the use of medical hypnosis in anesthesia to alleviate patients' stress and anxiety during medical procedures. In addition to its software solutions, the company offers specialized hardware designed for medical applications, catering to health professionals and institutions seeking innovative approaches to enhance patient care.

Emergence Therapeutics

Series A in 2021
Emergence Therapeutics AG develops novel antibody drug conjugate (ADC) immuno-therapeutics to treat high need cancers. The company was incorporated in 2019 and is based in Duisburg, Germany.

Kinvent

Venture Round in 2021
KINVENT is actively involved in the fields of physical rehabilitation and sports biomechanics producing innovative measuring and training devices for the facilitation of every day and athletic movements. Our strengths at KINVENT is that we can think and produce solutions to any challenge of sports biomechanics and physical rehabilitation. Triangular force plates for visual feedback balance training, sensors for continuous 3D kinematic analysis in the water, force sensors for kite surf, accelerometers for rowing and sailing, are some of our on demand products. If you are looking for excellence in hardware and software solutions for your work... work with us. Our KFORCE solution is a range of torque measuring instruments for human strength, balance and motion. This system consists of six instruments with high-precision measuring equipment, which concentrate all the know-how of K-INVENT. The display of the data recorded by the device sensors is transcribed by the KFORCE software, installed on any iOS or Android terminal. This accessory capable of reading and re-transcribing the information given by all dynamometers of the entire range is usable on smartphones or tablets with Android and IOS operating system

NewHeat

Venture Round in 2021
NewHeat is a company based in Begles, France, that specializes in the ownership and operation of solar heat production plants. Founded in 2015, it focuses on the financing, engineering, procurement, construction, and operation of these facilities. NewHeat transforms solar radiation into usable heat, utilizing solar thermal collectors to convert solar energy into water, steam, and thermal oil. The company's activities contribute to the renewable energy sector by harnessing solar energy for practical applications.

Quandela

Venture Round in 2021
Quandela SAS manufactures photonic cubic and semiconductor chips for quantum computing. Its product E-delight is a solid state source of single and highly indistinguishable photons for quantum applications. Quandela SAS was incorporated in 2017 and is based in Palaiseau, France.

Groover

Venture Round in 2021
Groover, SAS operates an online platform for sharing music tunes and receiving feedback. The company allows users to send tunes to blogs, radios, playlists, independent journalists, labels, and bookers for an amount of money in virtual currency, Grooviz, through an online platform. It also allows users to receive the feedback from online community of music influencers. It serves the music and entertainment industry. The company was incorporated in 2018 and is headquartered in Vauville, France.

iFollow

Series A in 2021
iFollow SAS, founded in 2017 and headquartered in Meudon, France, specializes in the development and manufacturing of autonomous support robots tailored for the logistics and food sectors. The company's offerings include iLogistics, an autonomous navigation trolley designed for warehouse operations, and iRetail, a smart cart that provides real-time information and guidance about products in retail environments. Additionally, iFollow produces autonomous robots for food order preparation and packaging, enhancing efficiency and collaboration in both logistics and retail settings.

Egle Therapeutics

Series A in 2021
Egle Therapeutics SAS, a biotechnology company, develops immunotherapies targeting immune suppressor regulatory T-cells for oncology and autoimmune diseases. It develops Treg modulating drug pipeline, which includes computationally designed resurfaced IL-2 proprietary variants to engage or dis-engage Tregs. The company was founded in 2020 and is based in Paris, France.

Mindee

Series A in 2021
Mindee SAS, founded in 2018 and based in Paris, France, operates an online platform and application programming interface (API) that specializes in document processing. The platform offers a range of services including optical character recognition, file indexing, electronic file conversion, and document management integration. It focuses on various document types such as invoices, expense reports, financial statements, and legal contracts, providing efficient solutions for file search and retrieval. Mindee aims to enhance business operations by delivering customized artificial intelligence solutions, from initial prototyping to production and team training, ensuring a seamless integration of advanced technologies into organizational workflows.

Ask Mona

Series A in 2021
Developer of an artificial intelligence platform designed to provide access to cultural services. The company's application utilizes a virtual robotic assistance feature that is available anytime to visitors at cultural institutions, museums, monuments, theaters, local authorities, and many more which helps in answering queries and developing interactive tour routes, providing users with personal assistants adapted to their needs.

Swan

Series A in 2021
Swan is an online banking platform based in Paris, France, that enables businesses to create bank accounts and manage their financial transactions effectively. Founded in 2019, the company provides a banking API that allows businesses to integrate banking services on demand. Swan offers features such as the ability to issue master cards and generate International Bank Account Numbers (IBANs) for their accounts, facilitating seamless banking operations for companies.

Echoliv

Grant in 2021
Echoliv is a medical technology company specializing in artificial intelligence solutions for abdominal ultrasound. The company develops software designed to assist radiologists and hepatologists in early-stage screening for hepatocellular carcinoma, the most common type of liver cancer. Echoliv's flagship product, Ultraliv, employs advanced algorithms to identify nodules that may be overlooked by practitioners, enhancing diagnostic accuracy and improving patient care. By integrating AI into the ultrasound process, Echoliv aims to support healthcare professionals in delivering timely and effective treatment for liver cancer.

Luos

Grant in 2021
Get rid of electronics struggles thanks to an open source architecture to turn electronics devices and subsets as microservices.

Younited

Venture Round in 2021
Younited SA is a financial technology company that operates an online platform designed to connect individual lenders with borrowers, facilitating financial transactions without the need for traditional financial intermediaries. Founded in 2009 and headquartered in Paris, France, Younited aims to provide credit with full transparency, allowing borrowers to share their testimonials and experiences. The company, previously known as PRET d'UNION S.A. until its rebranding in March 2016, focuses on creating a streamlined and direct lending experience for its users.

Adeunis

Grant in 2021
Adeunis is a company based in Crolles, France, that specializes in designing, manufacturing, and marketing connected objects and Internet of Things (IoT) solutions for business applications worldwide. The company offers a diverse range of products, including radio frequency transmission modules, wireless transmission systems, and various sensors for temperature and other data readings. Adeunis serves multiple sectors, such as smart buildings, remote energy management, industrial optimization, connected agriculture, and transport. Additionally, the company provides customized radio solutions tailored to specific customer needs. Its services extend to on-site radio mapping, deployment, training, data processing, and sensor maintenance, enabling clients to effectively manage their buildings and operations.

iWire

Series A in 2021
iWire is a UAE based company established since 2009, providing IT services to enterprise clients. As the digital era is unfolding at a breath-taking pace, we are determined to provide leading-edge solutions in the following domains to address the new market realities. o Internet of Things o IT Optimization o Digital Transformation

Edflex

Series A in 2021
Online learning resources search engine

C12 Quantum Electronics

Grant in 2021
C12 Quantum Electronics develop reliable quantum processors with carbon nanotubes. Its unique technology reduces drastically the error rate, making the platform a prime candidate for noisy intermediate-scale quantum applications. The Paris, Ile-de-France, France-based company was formed in 2019 by Pierre and Matthieu Desjardins.

Pasqal

Series A in 2021
Pasqal SAS, founded in 2019 and headquartered in Paris, France, specializes in the manufacture of quantum information processors utilizing atomic arrays. The company focuses on developing full-stack quantum computing technology that simulates complex phenomena to facilitate scientific discovery. Its innovative approach employs qubits made of neutral atoms organized in large two-dimensional and three-dimensional arrays, which enables analog computing. This technology addresses a variety of challenges, including optimization, drug discovery, and machine learning, empowering organizations to tackle complex problems across these fields.

Zaion

Series A in 2021
Zaion SAS, founded in 2017 and headquartered in Paris, France, specializes in developing integrated solutions for oral and written conversations, including callbots and voicebots. The company focuses on automating customer interactions through its innovative voice customer relationship software and chatbot technology, which enables natural language processing for both calls and text-based conversations. Zaion's offerings facilitate the supervision of customer interactions, provide insightful reporting, and integrate seamlessly with information systems and customer relationship management platforms. As a European expert in customer relationship solutions enhanced by artificial intelligence, Zaion aims to streamline and improve the efficiency of customer service processes.

Arkhn

Series A in 2021
Arkhn is a platform specialist in healthcare data interoperability. Arkhn tackles the issue of accessing healthcare data.

Biophytis

Grant in 2021
Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Their goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need that have limited or no treatment options. To accomplish this goal, they have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.

Newsbridge

Series A in 2021
Newsbridge is a company based in Boulogne-Billancourt, France, that specializes in contribution and image processing solutions. Founded in 2016, it focuses on producing content for television channels, production houses, and agencies. Newsbridge offers AI-based video indexing tools designed to assist publishers and broadcasters in streamlining their production processes and enhancing the value of their content through improved indexing.

OncoDiag

Grant in 2021
OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. Its lead product the Urotest (CE-IVD) is a urine test for diagnosis and surveillance of bladder cancer. The company's pipeline also includes the Colodiag in development for early detection of colorectal cancer.

Tekyn

Series A in 2021
Tekyn SAS operates a platform, which organizes the production and logistics of clothes. The company allows brands to produce apparel in five business days. It provides integration and management of patronages. Tekyn SAS was founded in 2017 and is headquartered in Paris, France.

Babylone Growers

Series A in 2021
Babylone Growers is a hydroponic greenhouse producer of vegetables and fruits using a vertical farming structure (X-frame).

Luos

Grant in 2021
Get rid of electronics struggles thanks to an open source architecture to turn electronics devices and subsets as microservices.

Powder

Series A in 2021
Powder is a startup that helps to share video clips of favorite games, follow people with the same interests and interact with them.

Lovys

Series A in 2021
Lovys is a digital insurance provider based in France. The company was founded in 2017. Lovys is the first 100% digital, all-in-one and flexible insurance in France. They are rethinking the entire user experience so that insurance becomes finally simple, transparent and personal. One interface, one monthly subscription for all insurance needs. Choose another insurance experience! Register on www.Lovys.fr to access the Beta version available soon.

Kwit

Series A in 2021
Kwit develops smoking cessation scientific methods and helps you on a daily basis with positivity and kindness.

Sis ID

Series A in 2021
The My Sis ID platform is the first community of financial departments that preserves transfer fraud by pooling banking identities and their control costs.

Antaios

Series A in 2020
Antaios develops innovative memory technology. Antaios is fully engaged in bringing the technology to the market to help chip manufacturers solve the critical issue of exploding power requests in advanced semiconductor systems.

In&Motion

Venture Round in 2020
In & Motion creates wearable smart protection systems that reduces risks of serious injuries due to falls. The company has launches the smart ski airbag vest that measure & analyse in real time skiers’ movements and anticipates falls in order to activate the airbag bladder before the impact. Protection is optimum on both broad and crucial areas. The smart ski airbag vest received several awards, was worn in 2015-16 Ski cross World Cup by racers from 7 major countries and will be available in stores since September via our partner, the Swedish brand POC.
OSE Immunotherapeutics is a biotechnology company led by world-class immunologists and focused on the development of innovative immunotherapies for immune activation and regulation in the fields of immuno-oncology, auto-immune diseases and transplantation.

bybr

Grant in 2020
ByBr operates a mobile application that facilitates the connection between consumers and brands through a simple interface that allows users to either type or scan brand names or logos. The app provides immediate access to localized official information, including websites, social media links, contact details, and messaging options, allowing for effortless interaction. Additionally, ByBr serves as an online platform for influencer and brand marketing, enabling brands to discover and collaborate with influential creators worldwide. This marketplace streamlines the process of communication and campaign management, while also ensuring secure payment methods for both brands and influencers. ByBr aims to enhance consumer engagement with brands and provide a seamless experience for users and marketers alike.

AlgoTherapeutix

Series A in 2020
AlgoTherapeutix SAS is a biotechnology company founded in 2018 and located in Suresnes, France, focused on developing innovative topical treatments for complex pain conditions. The company's primary product, ATX01, is designed to alleviate peripheral neuropathic pain caused by chemotherapy. By targeting the damaged nerve fibers in the skin, AlgoTherapeutix aims to provide effective pain relief while minimizing the systemic side effects associated with oral medications. The company's approach also addresses other pain syndromes, such as erythromelalgia, thereby offering medical practitioners new options to enhance patient care for those suffering from chemotherapy-induced peripheral neuropathy.

Preligens

Series A in 2020
We develop pioneering technology to empower analysts to take smart actions for a safer world. Our artificial intelligence solutions are based on an automated analysis of geospatial intelligence (GEOINT) workflows. Powering state-of-the-art Machine Learning and Computer Vision, we aggregate information from multi-intelligence sources (Multi-INT), such as imagery (IMINT), electromagnetic (ELINT), or open source (OSINT), to provide our Defence and Intelligence customers with strategic knowledge regarding mission critical areas of interest ensuring a more insightful operating picture.

SparingVision

Venture Round in 2020
SparingVision SAS is a biotechnology company based in Paris, France, focused on discovering and developing gene therapy-based treatments for blinding inherited retinal diseases. Founded in 2016, the company is working on SPVN06, a gene-independent therapy aimed at treating retinitis pigmentosa, the most common form of inherited retinal degeneration. This condition affects nearly 2 million people globally and currently lacks comprehensive treatment options for its various genetic forms. SparingVision’s efforts aim to provide innovative solutions for patients suffering from these debilitating diseases, enabling healthcare professionals to offer improved care for those at risk of blindness.

Medaviz

Series A in 2020
Medaviz is a online platform which provides medical advice to bring patients and doctors into immediate contact.

Garantme

Series A in 2020
Garantme is a broker specializing in insurance and banking services, primarily focused on providing rent guarantees in France. Established in 2017 and headquartered in Saint-Ouen, the company offers solutions that protect rental income for landlords through solvency and partner insurances. In addition to its guarantee services, Garantme features a platform called Garantme search, which assists clients in finding suitable accommodation. The company specifically caters to a diverse clientele, including international students, by guaranteeing their leases and enhancing their rental applications.

Multiwave Imaging

Grant in 2020
Multiwave Imaging is a French company recognized as a leader in the design of metamaterial MRI antennas. It operates as a wholly owned subsidiary of Multiwave Technologies AG, which was founded in Switzerland in March 2015 and has its headquarters in Geneva. The company focuses on developing innovative metamaterial technologies aimed at enhancing quality of life. Multiwave Imaging's primary objective is to create and harness intellectual property, assess its commercial viability, and establish management teams to transform these innovations into marketable products. This strategic approach enables Multiwave Imaging to build companies across various sectors, leveraging advanced technology to address diverse needs.

Exotrail

Series A in 2020
Exotrail SA, founded in 2015 and based in Palaiseau, France, specializes in developing electric propulsion systems and flight software for small satellites and their constellations. The company offers ExoMS, an innovative propulsion system designed to enable small satellite constellations to reach new orbits, and ExoOPS, a cloud-based software that aids engineers in designing and planning satellite missions. Exotrail's electric thrusters, specifically tailored for nano and micro-satellites, are utilized in various applications, including telecommunications, earth observation, and scientific research. The company's technology aims to create agile satellite constellations that enhance capabilities in these critical areas.

Osivax

Grant in 2020
​Osivax is a developer of immunotherapy vaccines intended to facilitate the treatment of infectious diseases. The company's vaccines expedite the uptake into dendritic cells and increase the immunogenicity of the natural protein to trigger a more effective immune response, including an unprecedented CD8 T cell activation, enabling medical practitioners to treat patients with cancer as well as influenza, malaria and other infectious diseases effectively.

Synapse Medicine

Venture Round in 2020
Synapse Medicine offers healthcare professionals such as doctors and pharmacists an easy way to look up reliable, up-to-date information about medications, to analyze prescriptions in real-time, and to ensure the safety of drug therapies.

Xenothera

Grant in 2020
Xenothera SAS, a biotechnology company, develops a platform with embedded technology that renovates immunological treatments. It develops new therapeutic modes in various domains from immunomodulation to infectious diseases. It addresses unmet medical needs with proprietary Glyco-Humanized Antibodies. The company’s therapeutic modes are based on animal genetics and mastery of immunology processes. It renovates passive immunotherapy by marketing a new generation of hyperimmune polyclonal sera. Xenothera SAS was incorporated in 2014 and is based in Nantes, France.

Owkin

Series A in 2020
Owkin is an artificial intelligence company founded in 2016, with headquarters in New York and an additional office in Paris. The company focuses on developing machine learning software for medical research, enabling researchers to test AI models on distributed data. Owkin's offerings include Owkin Lab, which facilitates data connectivity by therapeutic area; Owkin Loop, which provides validated and packaged models; and a comprehensive software stack for full-stack services. The company currently has 30 live models and an additional 40 in development. Owkin aims to empower medical researchers in hospitals, universities, and pharmaceutical companies to better understand variations in drug efficacy among patients, enhance the drug development process, and identify optimal treatments for individual patients, ultimately improving treatment outcomes. The company is supported by various investors and has a scientific board to guide its research initiatives.

ABC Transfer

Series A in 2020
ABC Transfer is a biopharmaceutical company that specializes in the development of Rapid Transfer Systems (RTS) for the pharmaceutical industry. The company manufactures secure transfer systems designed specifically for sterile drug manufacturing and bioprocessing. Its innovative solutions include alpha doors, beta containers, and single-use bags, all built on patented designs. These systems enhance sterility assurance, improve operator safety, and increase overall efficiency in drug manufacturing processes. Through its focus on secure and efficient transfer methods, ABC Transfer aims to support the biopharmaceutical industry's critical need for reliable and safe drug production.

Quantum Surgical

Grant in 2020
Quantum Surgical is a provider of surgical robotics focused on developing innovative solutions for minimally invasive surgeries. The company is creating a novel robotic platform designed to enhance the assessment, planning, and treatment of medical conditions. Its technology supports advanced percutaneous ablation therapy, particularly for liver cancer treatment, aiming to improve patient outcomes and enhance the safety of interventional oncology procedures. With a commitment to delivering effective clinical solutions, Quantum Surgical seeks to represent unique spinal products and treatment options, benefiting both physicians and patients throughout the continuum of care.

Ona Therapeutics

Series A in 2020
Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.

Ambler

Series A in 2020
Ambler SAS, founded in 2018 and headquartered in Paris, France, offers a digital platform that facilitates the booking of private ambulances, medical transportation services, and approved taxis for individuals and healthcare institutions. The company aims to streamline the process of medical transport by connecting healthcare prescribers with ambulance operators through an efficient online system that is secure and free for users. Ambler aggregates a substantial fleet of vehicles through strategic partnerships, ensuring high availability and responsiveness to the growing demand for medical transportation driven by demographic changes and regulatory reforms in the healthcare sector. Supported by both public authorities and notable private investors, Ambler is positioned as a unique solution in the marketplace for medical transport services.

Didomi

Series A in 2020
Didomi is a consent and preference management platform for collecting and leveraging user consents and preferences for businesses.The company's cloud-based suite of tools includes automated websites/apps scanning and auditing, privacy compliance assessment, privacy and cookie policy generation, and consent management, enabling businesses of all sizes to comply with privacy requirements and build consumer trust.

Shipup

Series A in 2020
Shipup SAS develops an application software that tracks packages in real-time to offer delivery notifications. It facilitates tracking of parcels delivered by e-merchants and share feedbacks. The company was founded in 2016 and is based in Boulogne-Billancourt, France.

Monstock

Series A in 2020
Monstock SAS, founded in 2016 and based in Bezannes, France, provides a mobile application designed for inventory and flow management. The software, available on Google Play and the App Store, simplifies stock management for businesses, enabling them to digitize their inventory processes efficiently. Monstock aims to facilitate this transition with a user-friendly solution that aligns with the varying capabilities of different companies, promoting ease of use and accessibility in inventory management.

Owkin

Series A in 2020
Owkin is an artificial intelligence company founded in 2016, with headquarters in New York and an additional office in Paris. The company focuses on developing machine learning software for medical research, enabling researchers to test AI models on distributed data. Owkin's offerings include Owkin Lab, which facilitates data connectivity by therapeutic area; Owkin Loop, which provides validated and packaged models; and a comprehensive software stack for full-stack services. The company currently has 30 live models and an additional 40 in development. Owkin aims to empower medical researchers in hospitals, universities, and pharmaceutical companies to better understand variations in drug efficacy among patients, enhance the drug development process, and identify optimal treatments for individual patients, ultimately improving treatment outcomes. The company is supported by various investors and has a scientific board to guide its research initiatives.

Vestiaire Collective

Venture Round in 2020
Vestiaire Collective is a social commerce platform that specializes in the resale of luxury and designer fashion items. Founded in 2009 and headquartered in Paris, the company connects a global community of over 7.5 million members across 50 countries, facilitating the buying and selling of pre-owned fashion products. Each week, more than 30,000 new items are added by sellers, providing buyers with access to thousands of curated luxury pieces daily. The platform features a diverse range of verified vintage and designer clothing, jewelry, accessories, and footwear, ensuring a trusted and sustainable shopping experience. In addition to its Paris headquarters, Vestiaire Collective operates offices in major cities such as London, New York, Milan, Berlin, and Hong Kong.

Pixpay

Series A in 2020
In an increasingly cashless society, most teens have neither an online bank account nor a payment card. They can't earn, spend or save digitally. So, they built Pixpay: an awesome financial tool for the 10-18 yo with parental oversight.

Multiwave Imaging

Grant in 2020
Multiwave Imaging is a French company recognized as a leader in the design of metamaterial MRI antennas. It operates as a wholly owned subsidiary of Multiwave Technologies AG, which was founded in Switzerland in March 2015 and has its headquarters in Geneva. The company focuses on developing innovative metamaterial technologies aimed at enhancing quality of life. Multiwave Imaging's primary objective is to create and harness intellectual property, assess its commercial viability, and establish management teams to transform these innovations into marketable products. This strategic approach enables Multiwave Imaging to build companies across various sectors, leveraging advanced technology to address diverse needs.

WAAM Cosmetics

Series A in 2020
WAAM Cosmetics is a company based in Savigny-sur-Orge, France, specializing in the manufacture and online sale of natural and eco-friendly cosmetic products. Founded in 2016, the company offers a diverse range of items, including vegetable and essential oils, butter creams, clays, floral waters, powders, scrubs, and various skin and hair care products. WAAM Cosmetics emphasizes the use of high-quality raw materials sourced from fair trade, ensuring that its offerings are vegan and cruelty-free. In addition to finished products, the company provides empty containers, molds, tools, and DIY recipe kits to facilitate personalized beauty solutions.

Vulkam

Grant in 2020
Vulkam SAS, a micro technology company, engages in the design, development, and production of amorphous metal parts. The company’s amorphous metals are primarily composed of zirconium, copper, hafnium, nickel, or titanium. Its products have applications in aerospace, automotive, biomedical, cryogenic, watches, jewellery, micro components, and micro fluids industries. Vulkam SAS was founded in 2017 and is based in Saint-Martin-d'Hères, France.

Fair&Smart

Venture Round in 2020
Fair&Smart is a Human-centric platform for the governance and free-flow of personal data. It provides people with more control over their personal data and companies with Privacy compliance and up-to-date data.

Cardiologs

Series A in 2020
Cardiologs Technologies SAS is a medical technology company based in Paris, France, that specializes in electrocardiogram (ECG) analysis to enhance cardiac patient management. Founded in 2014, the company offers the Cardiologs ECG Analysis Platform, a cloud-based service designed to assist physicians in screening for atrial fibrillation and other arrhythmias through long-term ambulatory ECG monitoring. Utilizing a proprietary database of over 1.4 million recordings and advanced deep learning technology, Cardiologs' solution is backed by clinical publications demonstrating its diagnostic effectiveness. The platform enables cardiologists to identify patterns in digital ECG signals from various compatible cardiac monitoring devices, ultimately aiming to make expert cardiac diagnostics more scalable and accessible within the healthcare sector.

Naïo Technologies

Series A in 2020
Naio Technologies develops and markets machines for agriculture and viticulture. It features electric tools for weeding, hoeing, and harvesting that help farmers collect and harvest their products. The company specializes in agriculture, AI, robotics, and Agtech. Naio Technologies was founded in 2011 and headquartered in Midi-Pyrenees, France.

VectivBio

Series A in 2020
VectivBio is a clinical-stage biotechnology company bringing transformational medicines to patients with serious rare diseases. They are committed to pursuing rare diseases with well-defined biology that can be targeted with best-in-disease therapies that have the potential to meaningfully transform and improve the lives of patients and their families, not just provide an incremental improvement or benefit over the standard-of-care. It was founded as a spinout from Therachon, a biotechnology company acquired by Pfizer for its program in achondroplasia. VectivBio was incorporated in 2019 and is based in Basel, Switzerland.

Majelan

Series A in 2019
Majelan SAS, founded in 2018 and based in Paris, France, operates a platform that enables users to discover and listen to podcasts and other audio content. The company has developed software designed to enhance the entertainment experience by allowing users to search for and access a diverse array of audio content on their iOS or Android smartphones. This platform caters to podcast enthusiasts, offering them a convenient and user-friendly way to explore different audio materials.

Combo

Venture Round in 2019
Snapshift is a staff management web solution for restaurants. The company's software enables restaurant owners to make online scheduling and enter the information on contracts, endorsements, proofs, leave requests, time sheets which will be stored online, enabling restaurant owners spend less time on administrative tasks so they can focus on their customers.

Cherche mon nid

Venture Round in 2019
When they was a real estate agent, Antoine Huvé, the founder of rechercheemonnid.com, started from the double observation that it had become tedious for clients to search for real estate on the internet (many sites, imprecise locations, multiplication of contacts and registration, ....) and for professionals, it became very expensive and painful to have to multiply ads on different media to be able to get customer contacts without valuing its expertise and skills. The very simple idea of ​​Cherchemonnid.com appeared: To allow people in search of good to be able to contact ALL the professionals of a sector in a single step in order to receive CUSTOMIZED proposals and to cover the whole market.

ACINQ

Series A in 2019
ACINQ SAS develops the eclair software suite for bitcoin ecosystem. It also develops a payment wallet. The company was founded in 2014 and is based in Paris, France.